
James S. Bergin
Examiner (ID: 277, Phone: (571)272-6872 , Office: P/3641 )
| Most Active Art Unit | 3641 |
| Art Unit(s) | 3641, 3624, 3643, 2164, 3616 |
| Total Applications | 1851 |
| Issued Applications | 1400 |
| Pending Applications | 172 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20157016
[patent_doc_number] => 12383614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Mutants of respiratory syncytial virus fusion proteins
[patent_app_type] => utility
[patent_app_number] => 19/017356
[patent_app_country] => US
[patent_app_date] => 2025-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4796
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19017356
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/017356 | Mutants of respiratory syncytial virus fusion proteins | Jan 9, 2025 | Issued |
Array
(
[id] => 19989664
[patent_doc_number] => 20250127886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B
[patent_app_type] => utility
[patent_app_number] => 18/988667
[patent_app_country] => US
[patent_app_date] => 2024-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18988667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/988667 | ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B | Dec 18, 2024 | Pending |
Array
(
[id] => 20051303
[patent_doc_number] => 20250189525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => PREPARATION METHOD AND APPLICATION OF NANOBODY TARGETING DENGUE VIRUS NS1 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/955940
[patent_app_country] => US
[patent_app_date] => 2024-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18955940
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/955940 | Preparation method and application of nanobody targeting dengue virus NS1 protein | Nov 20, 2024 | Issued |
Array
(
[id] => 19998729
[patent_doc_number] => 20250136951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => METHOD FOR CONSTRUCTING gE GENE-DELETED PSEUDORABIES VIRUS STRAIN USING ADENINE BASE EDITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/903289
[patent_app_country] => US
[patent_app_date] => 2024-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18903289
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/903289 | Method for constructing gE protein-deleted pseudorabies virus strain using adenine base editor and use thereof | Sep 30, 2024 | Issued |
Array
(
[id] => 18710478
[patent_doc_number] => 20230333103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => BIOHAZARD ANALYZER
[patent_app_type] => utility
[patent_app_number] => 18/212168
[patent_app_country] => US
[patent_app_date] => 2023-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212168
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212168 | BIOHAZARD ANALYZER | Jun 19, 2023 | Pending |
Array
(
[id] => 19140521
[patent_doc_number] => 20240139312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => UNIVERSAL ADJUVANT FOR NASAL, ORAL, AND INTRAMUSCULAR DELIVERY OF VACCINES
[patent_app_type] => utility
[patent_app_number] => 18/196214
[patent_app_country] => US
[patent_app_date] => 2023-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18196214
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/196214 | UNIVERSAL ADJUVANT FOR NASAL, ORAL, AND INTRAMUSCULAR DELIVERY OF VACCINES | May 10, 2023 | Pending |
| 18/034933 | SPECIFIC REACTION MIXTURE FOR USE IN THE DIAGNOSIS OF COVID-19 WITH ISOTHERMAL AMPLIFICATION METHOD | May 1, 2023 | Pending |
Array
(
[id] => 18538714
[patent_doc_number] => 20230243818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => Low-Cost Rapid Diagnostic Biosensors
[patent_app_type] => utility
[patent_app_number] => 18/296613
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296613 | Low-Cost Rapid Diagnostic Biosensors | Apr 5, 2023 | Pending |
Array
(
[id] => 18770857
[patent_doc_number] => 20230365658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => REPAIRED THERAPEUTIC AND PROPHYLACTIC ANTIBODIES AGAINST SARS-CoV-2 VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/122658
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122658
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122658 | REPAIRED THERAPEUTIC AND PROPHYLACTIC ANTIBODIES AGAINST SARS-CoV-2 VARIANTS | Mar 15, 2023 | Pending |
Array
(
[id] => 18692598
[patent_doc_number] => 20230322906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => HIV-1 SPECIFIC ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/185067
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185067 | HIV-1 SPECIFIC ANTIBODIES AND USES THEREOF | Mar 15, 2023 | Pending |
Array
(
[id] => 20108247
[patent_doc_number] => 12358954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Capsid-modified rAAV vector compositions and methods therefor
[patent_app_type] => utility
[patent_app_number] => 17/929256
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 126
[patent_no_of_words] => 55649
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929256 | Capsid-modified rAAV vector compositions and methods therefor | Aug 31, 2022 | Issued |
Array
(
[id] => 18567497
[patent_doc_number] => 20230257831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD FOR DETERMINING AAV TITRE
[patent_app_type] => utility
[patent_app_number] => 17/823680
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823680 | METHOD FOR DETERMINING AAV TITRE | Aug 30, 2022 | Pending |
Array
(
[id] => 18239085
[patent_doc_number] => 20230071396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHOD OF DETECTING A RESPIRATORY VIRAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/896801
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/896801 | METHOD OF DETECTING A RESPIRATORY VIRAL INFECTION | Aug 25, 2022 | Pending |
Array
(
[id] => 18019086
[patent_doc_number] => 20220370585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => CURING CANCER WITH VIRAL VECTORED INJECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/881382
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881382 | CURING CANCER WITH VIRAL VECTORED INJECTIONS | Aug 3, 2022 | Pending |
Array
(
[id] => 19554955
[patent_doc_number] => 20240366747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS
[patent_app_type] => utility
[patent_app_number] => 18/574482
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/574482 | UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS | Jul 13, 2022 | Pending |
Array
(
[id] => 18078750
[patent_doc_number] => 20220404362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Methods and Systems for Detecting SARS-CoV-2 Analytes in Dried Samples
[patent_app_type] => utility
[patent_app_number] => 17/845502
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845502 | Methods and Systems for Detecting SARS-CoV-2 Analytes in Dried Samples | Jun 20, 2022 | Pending |
Array
(
[id] => 18075936
[patent_doc_number] => 20220401548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => SINDBIS VIRUS DNA-BASED VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/843425
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843425 | SINDBIS VIRUS DNA-BASED VACCINE | Jun 16, 2022 | Pending |
Array
(
[id] => 18210094
[patent_doc_number] => 20230056355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => NOVEL DUAL HELPER PLASMID
[patent_app_type] => utility
[patent_app_number] => 17/750241
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750241 | Dual helper plasmid | May 19, 2022 | Issued |
Array
(
[id] => 18658019
[patent_doc_number] => 20230303983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => HIGH EFFICIENCY PURIFICATION OF DIVERGENT AAV SEROTYPES USING AAVX AFFINITY CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/743444
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743444 | HIGH EFFICIENCY PURIFICATION OF DIVERGENT AAV SEROTYPES USING AAVX AFFINITY CHROMATOGRAPHY | May 11, 2022 | Pending |
Array
(
[id] => 17988907
[patent_doc_number] => 20220354944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM
[patent_app_type] => utility
[patent_app_number] => 17/736452
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736452 | CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM | May 3, 2022 | Pending |